We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA OKed Email Monitoring of CDRH Scientists, Senator Says
FDA OKed Email Monitoring of CDRH Scientists, Senator Says
July 20, 2012
Lawmakers and watchdog groups are putting a brighter spotlight on the FDA, demanding the agency, HHS and the White House take action to ensure whistleblower protections and investigate allegations of inappropriate email monitoring by the drug regulator.